Innovations to promote communication between primary care providers, oncologists are vital to delineate distinct roles in oncology patient management, said Kelly Filchner, MSN, director at Fox Chase Cancer Center Partners.
Innovations to promote communication between primary care providers, oncologists are vital to delineate distinct roles in oncology patient management, said Kelly Filchner, MSN, director at Fox Chase Cancer Center Partners.
Transcript
What are the best practices for quantifying and communicating the value of survivorship care offered by primary care physicians (PCPs)?
I think first of all, the PCPs have core competencies and education that they probably need. They want to be part of the care team. They're very comfortable with preventative care and lifestyle, like helping people with obesity and exercise, but they might not be quite as comfortable with the other portions of survivorship, such as the long term surveillance and possible side effects. So, those are the things we have to look at when we're developing programs and trying to get things started with PCPs.
What are the most prominent barriers preventing successful integration of primary care providers into oncology patient management?
Well, start with electronic medical records (EMRs)—they're probably a help and a hindrance. So, it's great that we have them, but they're not perfect, and you might have a patient that sees physicians in multiple systems. So, then you have to make sure those EMRs talk to each other. It's a good way of making sure communication occurs between the physicians. The other part of that is that if we develop survivorship care plans, and they're in the electronic medical record, where do they live? So, I did a random search where I work on where we keep those survivorship care plans, and I kind of found them in a couple different places. Even though the PCPs are in our system, they can actually enter the records because they're part of the system and they can look for those care plans. I don't know if they'd know where to look, because we haven't really told them. So, I think that's 1 of the big barriers there.
Another one is confusion about who's supposed to do what. So, what is the PCP supposed to take care of versus what is the oncologist supposed to take care of. So, there's a lot of research out there about different models of care and who should lead survivorship. Again, I'm going to go back to the United Kingdom, they've done a lot of work with self-management of patients—so they risk-stratify the patients to see which ones can manage their follow up and making sure they get to the resources they need on their own, versus a patient who needs a little bit more provider support. They've implemented this in many of their, they call them trusts in the United Kingdom, and it's been very successful.
So, we need to be a little bit more innovative. I know it's not going to be easy because we have so many different types of healthcare systems here in the US and all different kinds of insurances and things like that—just makes things a little bit more tricky. I think policy and the payers are another big part of it because we need to have support to be able to give the survivorship care that we should be giving, and some of that might be, do we need to carve out special codes or whatever for those types of visits so that the patients can get what they need.
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
NCCN Data Find Racial, Socioeconomic Disparities in Quality of Care for Metastatic Pancreatic Cancer
April 9th 2025New data from the National Comprehensive Cancer Network (NCCN) reveal that socially vulnerable and minority patients with metastatic pancreatic cancer are less likely to receive recommended treatments and achieve longer survival.
Read More